Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications
Stroke represents a massive public health problem. Carotid atherosclerosis plays a
fundamental part in the occurence of ischaemic stroke. European and US guidelines for …
fundamental part in the occurence of ischaemic stroke. European and US guidelines for …
Assessing the interactions between radiotherapy and antitumour immunity
C Grassberger, SG Ellsworth, MQ Wilks… - Nature reviews Clinical …, 2019 - nature.com
Immunotherapy, specifically the introduction of immune checkpoint inhibitors, has
transformed the treatment of cancer, enabling long-term tumour control even in individuals …
transformed the treatment of cancer, enabling long-term tumour control even in individuals …
Oxidized phospholipids on lipoprotein (a) elicit arterial wall inflammation and an inflammatory monocyte response in humans
Background: Elevated lipoprotein (a)[Lp (a)] is a prevalent, independent cardiovascular risk
factor, but the underlying mechanisms responsible for its pathogenicity are poorly defined …
factor, but the underlying mechanisms responsible for its pathogenicity are poorly defined …
Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography …
MN Pizzi, A Roque, N Fernández-Hidalgo… - Circulation, 2015 - Am Heart Assoc
Background—The diagnosis of infective endocarditis (IE) in prosthetic valves and
intracardiac devices is challenging because both the modified Duke criteria (DC) and …
intracardiac devices is challenging because both the modified Duke criteria (DC) and …
Contemporary carotid imaging: from degree of stenosis to plaque vulnerability
W Brinjikji, J Huston, AA Rabinstein, GM Kim… - Journal of …, 2016 - thejns.org
Carotid artery stenosis is a well-established risk factor of ischemic stroke, contributing to up
to 10%-20% of strokes or transient ischemic attacks. Many clinical trials over the last 20 …
to 10%-20% of strokes or transient ischemic attacks. Many clinical trials over the last 20 …
Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography …
Objectives: The study sought to test whether high-dose statin treatment would result in
greater reductions in plaque inflammation than low-dose statins, using fluorodeoxyglucose …
greater reductions in plaque inflammation than low-dose statins, using fluorodeoxyglucose …
PET imaging of inflammation in atherosclerosis
PET imaging of atherosclerosis can quantify several in vivo pathological processes
occurring within the arterial system. 18F-fluorodeoxyglucose (FDG) is the most-commonly …
occurring within the arterial system. 18F-fluorodeoxyglucose (FDG) is the most-commonly …
Arterial inflammation in patients with HIV
Context Cardiovascular disease is increased in patients with human immunodeficiency virus
(HIV), but the specific mechanisms are unknown. Objective To assess arterial wall …
(HIV), but the specific mechanisms are unknown. Objective To assess arterial wall …
Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events
AL Figueroa, A Abdelbaky, QA Truong, E Corsini… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives: This study sought to determine whether arterial inflammation measured by 18F-
fluorodeoxyglucose positron emission tomography (18F-FDG-PET) improves prediction of …
fluorodeoxyglucose positron emission tomography (18F-FDG-PET) improves prediction of …
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
Background Dalcetrapib modulates cholesteryl ester transfer protein (CETP) activity to raise
high-density lipoprotein cholesterol (HDL-C). After the failure of torcetrapib it was unknown if …
high-density lipoprotein cholesterol (HDL-C). After the failure of torcetrapib it was unknown if …